AYAL Capital Advisors Ltd purchased a new stake in Calumet, Inc. (NASDAQ:CLMT – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 335,000 shares of the oil and gas company’s stock, valued at approximately $5,278,000. Calumet accounts for approximately 1.3% of AYAL Capital Advisors Ltd’s portfolio, making the stock its 21st biggest position. AYAL Capital Advisors Ltd owned approximately 0.39% of Calumet at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Goldman Sachs Group Inc. increased its holdings in shares of Calumet by 33.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 465,269 shares of the oil and gas company’s stock valued at $5,900,000 after purchasing an additional 116,777 shares in the last quarter. Adams Asset Advisors LLC grew its position in Calumet by 0.9% during the second quarter. Adams Asset Advisors LLC now owns 5,406,271 shares of the oil and gas company’s stock valued at $85,176,000 after buying an additional 49,948 shares during the period. Caldwell Sutter Capital Inc. increased its holdings in Calumet by 29.9% in the second quarter. Caldwell Sutter Capital Inc. now owns 19,483 shares of the oil and gas company’s stock valued at $307,000 after buying an additional 4,483 shares in the last quarter. Wasserstein Debt Opportunities Management L.P. increased its holdings in Calumet by 3.2% in the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 5,817,012 shares of the oil and gas company’s stock valued at $91,647,000 after buying an additional 180,197 shares in the last quarter. Finally, O Keefe Stevens Advisory Inc. raised its position in shares of Calumet by 12.1% in the second quarter. O Keefe Stevens Advisory Inc. now owns 26,817 shares of the oil and gas company’s stock worth $423,000 after acquiring an additional 2,903 shares during the period. Institutional investors and hedge funds own 34.41% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on CLMT. The Goldman Sachs Group raised their target price on Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a report on Monday. Wall Street Zen upgraded Calumet from a “hold” rating to a “buy” rating in a research report on Saturday, December 6th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, TD Cowen lifted their price target on shares of Calumet from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, November 11th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $20.04.
Calumet Stock Performance
NASDAQ CLMT opened at $20.46 on Friday. The business has a fifty day moving average price of $19.14 and a 200 day moving average price of $17.15. The company has a market cap of $1.77 billion, a P/E ratio of -47.58 and a beta of 1.18. Calumet, Inc. has a one year low of $7.68 and a one year high of $23.75.
Calumet (NASDAQ:CLMT – Get Free Report) last announced its earnings results on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.06 billion. The company’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the firm earned ($1.18) EPS. As a group, sell-side analysts predict that Calumet, Inc. will post -3.02 EPS for the current fiscal year.
Calumet Profile
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
See Also
- Five stocks we like better than Calumet
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- CD Calculator: Certificate of Deposit Calculator
- The Best Holiday Present You Can Give Yourself? Costco Stock
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT – Free Report).
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
